Management tracks: Iovance, ViiV, Hercules, Pappas and more

Cancer immunotherapy company Iovance Biotherapeutics Inc. (NASDAQ:IOVA) hired Friedrich Graf Finckenstein as CMO. He was global head of oncology translational medicine of the Pharma Research and Early Development (pRED) unit of Roche (SIX:ROG; OTCQX:RHHBY).

ViiV Healthcare Ltd. (Brentford, U.K.) said John Pottage is stepping down as SVP and chief scientific and medical officer. He will be

Read the full 550 word article

How to gain access

Continue reading with a
two-week free trial.